To determine the efficacy and toxicity of higher dose versus standard dose intravenous methotrexate ( MTX ) and pulses of high-dose cytosine arabinoside with asparaginase versus standard dose cytosine arabinoside and teniposide during intensified continuation therapy for higher risk pediatric B-precursor acute lymphoblastic leukemia ( ALL ) .